{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T07:00:13Z","timestamp":1792047613091,"version":"4.4.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T00:00:00Z","timestamp":1648857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T00:00:00Z","timestamp":1648857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1038\/s41409-022-01650-5","type":"journal-article","created":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T00:02:47Z","timestamp":1648857767000},"page":"911-917","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Age is no barrier for adults undergoing HCT for AML in CR1: contemporary CIBMTR analysis"],"prefix":"10.1038","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1732-6694","authenticated-orcid":false,"given":"Joseph E.","family":"Maakaron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8578-1226","authenticated-orcid":false,"given":"Sunil","family":"Abhyankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2513-0533","authenticated-orcid":false,"given":"Vijaya Raj","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9117-8696","authenticated-orcid":false,"given":"Saurabh","family":"Chhabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9268-9655","authenticated-orcid":false,"given":"Najla","family":"El Jurdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3088-843X","authenticated-orcid":false,"given":"Sherif S.","family":"Farag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0782-1170","authenticated-orcid":false,"given":"Fiona","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Juckett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8568-4522","authenticated-orcid":false,"given":"Marcos","family":"de Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navneet","family":"Majhail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein","family":"van der Poel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0003-0130","authenticated-orcid":false,"given":"Ayman","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bipin","family":"Savani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6896-6213","authenticated-orcid":false,"given":"Celalettin","family":"Ustun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund K.","family":"Waller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9816-6302","authenticated-orcid":false,"given":"Mark","family":"Litzow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8607-9404","authenticated-orcid":false,"given":"Partow","family":"Kebriaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"Hourigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael","family":"Saber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8078-8579","authenticated-orcid":false,"given":"Daniel","family":"Weisdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,2]]},"reference":[{"key":"1650_CR1","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.3324\/haematol.2012.066100","volume":"97","author":"B Oran","year":"2012","unstructured":"Oran B, Weisdorf DJ. Survival for older patients with acute myeloid leukemia: a population-based study. Haematologica. 2012;97:1916\u201324. https:\/\/doi.org\/10.3324\/haematol.2012.066100.","journal-title":"Haematologica"},{"key":"1650_CR2","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/j.1365-2141.2010.08470.x","volume":"152","author":"DA Pollyea","year":"2011","unstructured":"Pollyea DA, Kohrt HE, Medeiros BC. Acute myeloid leukaemia in the elderly: a review. Br J Haematol. 2011;152:524\u201342.","journal-title":"Br J Haematol"},{"key":"1650_CR3","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1182\/blood-2006-05-021907","volume":"109","author":"E Estey","year":"2007","unstructured":"Estey E, de Lima M, Tibes R, Pierce S, Kantarjian H, Champlin R, et al. Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS). Blood. 2007;109:1395\u20131400. https:\/\/doi.org\/10.1182\/blood-2006-05-021907.","journal-title":"Blood."},{"key":"1650_CR4","doi-asserted-by":"publisher","unstructured":"Flannelly C, Tan BEX, Tan JL, McHugh CM, Sanapala C, Lagu T, et al. Barriers to hematopoietic cell transplantation for adults in the united states: a systematic review with a focus on age. Biol Blood Marrow Transplant. Published online 20 Sept 2020. https:\/\/doi.org\/10.1016\/j.bbmt.2020.09.013.","DOI":"10.1016\/j.bbmt.2020.09.013"},{"key":"1650_CR5","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/s41409-018-0105-9","volume":"53","author":"VR Bhatt","year":"2018","unstructured":"Bhatt VR, Chen B, Lee SJ. Use of hematopoietic cell transplantation in younger patients with acute myeloid leukemia: a national cancer database study. Bone Marrow Transpl. 2018;53:873\u20139. https:\/\/doi.org\/10.1038\/s41409-018-0105-9.","journal-title":"Bone Marrow Transpl"},{"key":"1650_CR6","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1200\/JCO.2005.05.694","volume":"23","author":"H Wallen","year":"2005","unstructured":"Wallen H, Gooley TA, Deeg HJ, Pagel JM, Press OW, Appelbaum FR, et al. Ablative allogeneic hematopoietic cell transplantation in adults 60 years of age and older. J Clin Oncol. 2005;23:3439\u201346. https:\/\/doi.org\/10.1200\/JCO.2005.05.694.","journal-title":"J Clin Oncol"},{"key":"1650_CR7","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.bbmt.2015.10.019","volume":"22","author":"A Rashidi","year":"2016","unstructured":"Rashidi A, Ebadi M, Colditz GA, DiPersio JF. Outcomes of allogeneic stem cell transplantation in elderly patients with acute myeloid leukemia: a systematic review and meta-analysis. Biol Blood Marrow Transpl. 2016;22:651\u20137. https:\/\/doi.org\/10.1016\/j.bbmt.2015.10.019.","journal-title":"Biol Blood Marrow Transpl."},{"key":"1650_CR8","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","volume":"15","author":"A Bacigalupo","year":"2009","unstructured":"Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transpl. 2009;15:1628\u201333. https:\/\/doi.org\/10.1016\/j.bbmt.2009.07.004.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1650_CR9","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1001\/jamaoncol.2017.2714","volume":"3","author":"ML Sorror","year":"2017","unstructured":"Sorror ML, Storer BE, Fathi AT, Gerds A, Medeiros BC, Shami P, et al. Development and validation of a novel acute myeloid leukemia\u2013composite model to estimate risks of mortality. JAMA Oncol. 2017;3:1675\u201382. https:\/\/doi.org\/10.1001\/jamaoncol.2017.2714.","journal-title":"JAMA Oncol"},{"key":"1650_CR10","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1038\/bmt.2016.156","volume":"51","author":"M Pohlen","year":"2016","unstructured":"Pohlen M, Groth C, Sauer T, G\u00f6rlich D, Mesters R, Schliemann C, et al. Outcome of allogeneic stem cell transplantation for AML and myelodysplastic syndrome in elderly patients (\u2a7e60 years). Bone Marrow Transpl. 2016;51:1441\u20138. https:\/\/doi.org\/10.1038\/bmt.2016.156.","journal-title":"Bone Marrow Transpl"},{"key":"1650_CR11","doi-asserted-by":"publisher","unstructured":"Hourigan CS, Dillon LW, Gui G, Logan BR, Fei M, Ghannam J, et al. Impact of conditioning intensity of allogeneic transplantation for acute myeloid leukemia with genomic evidence of residual disease. J Clin Oncol. Published online 20 Dec 2019:JCO.19.03011. https:\/\/doi.org\/10.1200\/JCO.19.03011.","DOI":"10.1200\/JCO.19.03011"},{"key":"1650_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1182\/blood-2019-124659","volume":"134","author":"CN De Jong","year":"2019","unstructured":"De Jong CN, Meijer E, Bakunina K, Nur E, van Marwijk Kooij M, de Groot MR, et al. Post-transplantation cyclophosphamide after allogeneic hematopoietic stem cell transplantation: results of the prospective randomized HOVON-96 trial in recipients of matched related and unrelated donors. Blood. 2019;134:1\u20131. https:\/\/doi.org\/10.1182\/blood-2019-124659.","journal-title":"Blood"},{"key":"1650_CR13","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1182\/blood.V126.23.270.270","volume":"126","author":"SJ Lee","year":"2015","unstructured":"Lee SJ, Logan B, Westervelt P, Cutler CC, Woolfrey AE, Khan S, et al. 5 year results of BMT CTN 0201: unrelated donor bone marrow is associated with better psychological well-being and less burdensome chronic gvhd symptoms than peripheral blood. Blood. 2015;126:270. https:\/\/doi.org\/10.1182\/blood.V126.23.270.270.","journal-title":"Blood"},{"key":"1650_CR14","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1002\/cncr.28129","volume":"119","author":"MS Thein","year":"2013","unstructured":"Thein MS, Ershler WB, Jemal A, Yates JW, Baer MR. Outcome of older patients with acute myeloid leukemia. Cancer. 2013;119:2720\u20137. https:\/\/doi.org\/10.1002\/cncr.28129.","journal-title":"Cancer"},{"key":"1650_CR15","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/s41409-018-0164-y","volume":"53","author":"VR Bhatt","year":"2018","unstructured":"Bhatt VR, Chen B, Gyawali B, Lee SJ. Socioeconomic and health system factors associated with lower utilization of hematopoietic cell transplantation in older patients with acute myeloid leukemia. Bone Marrow Transpl. 2018;53:1288\u201394. https:\/\/doi.org\/10.1038\/s41409-018-0164-y.","journal-title":"Bone Marrow Transpl"},{"key":"1650_CR16","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1182\/blood-2017-03-772368","volume":"130","author":"L Muffly","year":"2017","unstructured":"Muffly L, Pasquini MC, Martens M, Brazauskas R, Zhu Z, Adekola K, et al. Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States. Blood. 2017;130:1156\u201364. https:\/\/doi.org\/10.1182\/blood-2017-03-772368.","journal-title":"Blood"},{"key":"1650_CR17","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1038\/s41375-019-0477-x","volume":"33","author":"C Ustun","year":"2019","unstructured":"Ustun C, Le-Rademacher J, Wang HL, Othus M, Sun Z, Major B, et al. Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60\u201375 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study. Leukemia. 2019;33:2599\u2013609. https:\/\/doi.org\/10.1038\/s41375-019-0477-x.","journal-title":"Leukemia"},{"key":"1650_CR18","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1200\/JCO.2016.70.7091","volume":"35","author":"BL Scott","year":"2017","unstructured":"Scott BL, Pasquini MC, Logan BR, Wu J, Devine SM, Porter DL, et al. Myeloablative versus reduced-intensity hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes. J Clin Oncol. 2017;35:1154\u201361. https:\/\/doi.org\/10.1200\/JCO.2016.70.7091.","journal-title":"J Clin Oncol"},{"key":"1650_CR19","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/sj.leu.2404741","volume":"21","author":"J Finke","year":"2007","unstructured":"Finke J, Nagler A. Viewpoint: What is the role of allogeneic haematopoietic cell transplantation in the era of reduced-intensity conditioning\u2014is there still an upper age limit? A focus on myeloid neoplasia. Leukemia. 2007;21:1357\u201362. https:\/\/doi.org\/10.1038\/sj.leu.2404741.","journal-title":"Leukemia"},{"key":"1650_CR20","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1200\/JCO.2005.03.1765","volume":"24","author":"U Hegenbart","year":"2006","unstructured":"Hegenbart U, Niederwieser D, Sandmaier BM, Maris M, Shizuru JA, Greinix H, et al. Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors. J Clin Oncol. 2006;24:444\u201353.","journal-title":"J Clin Oncol"},{"key":"1650_CR21","first-page":"1201","volume":"100","author":"HJ Deeg","year":"2002","unstructured":"Deeg HJ, Storer B, Slattery JT, Anasetti C, Doney KC, Hansen JA, et al. Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome. Blood J Am Soc Hematol. 2002;100:1201\u20137.","journal-title":"Blood J Am Soc Hematol"},{"key":"1650_CR22","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1399-0012.2005.00453.x","volume":"20","author":"M Ditschkowski","year":"2006","unstructured":"Ditschkowski M, Elmaagacli AH, Trenschel R, Steckel NK, Koldehoff M, Beelen DW. Myeloablative allogeneic hematopoietic stem cell transplantation in elderly patients. Clin Transpl. 2006;20:127\u201331. https:\/\/doi.org\/10.1111\/j.1399-0012.2005.00453.x.","journal-title":"Clin Transpl"},{"key":"1650_CR23","doi-asserted-by":"publisher","unstructured":"Polverelli N, Tura P, Battipaglia G, Malagola M, Bernardi S, Gandolfi L, et al. Multidimensional geriatric assessment for elderly hematological patients (\u226560 years) submitted to allogeneic stem cell transplantation. A French\u2013Italian 10-year experience on 228 patients. Bone Marrow Transplant. Published online 12 May 2020:1\u201310. https:\/\/doi.org\/10.1038\/s41409-020-0934-1.","DOI":"10.1038\/s41409-020-0934-1"},{"key":"1650_CR24","doi-asserted-by":"publisher","unstructured":"Munshi PN, Vesole D, Jurczyszyn A, Zaucha JM, St Martin A, Davila O, et al. Age no bar: a CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma. Cancer. https:\/\/doi.org\/10.1002\/cncr.33171.","DOI":"10.1002\/cncr.33171"},{"key":"1650_CR25","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1016\/j.bbmt.2020.04.013","volume":"26","author":"A D\u2019Souza","year":"2020","unstructured":"D\u2019Souza A, Fretham C, Lee SJ, Arora M, Brunner J, Chhabra S, et al. Current use of and trends in hematopoietic cell transplantation in the United States. Biol Blood Marrow Transpl. 2020;26:e177\u2013e182. https:\/\/doi.org\/10.1016\/j.bbmt.2020.04.013.","journal-title":"Biol Blood Marrow Transpl."}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-022-01650-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-022-01650-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-022-01650-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T12:05:12Z","timestamp":1655294712000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-022-01650-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,2]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["1650"],"URL":"https:\/\/doi.org\/10.1038\/s41409-022-01650-5","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,2]]},"assertion":[{"value":"20 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Daniel Weisdorf reports grants from FATE Therapeutics, grants from Incyte, outside the submitted work. Christopher S Hourigan reports other from Sellas, outside the submitted work. Joseph E Maakaron reports other from CRISPR, other from FortySeven Inc., other from TALARIS, outside the submitted work. Marcos de Lima reports grants from Pfizer grants from Celgene, personal fees from Kadmon personal fees from Pfizer, personal fees from Incyte, personal fees from BMS, outside the submitted work. Vijaya Raj Bhatt reports personal fees from Agios, grants and personal fees from Incyte, personal fees from Takeda, personal fees from Partner Therapeutics, personal fees from Omeros, grants and personal fees from Abbvie, grants from Jazz, grants from National Marrow Donor Program, other from Oncoceutics, personal fees from Partnership for health analytic research, LLC, grants and other from Pfizer, personal fees from CSL Behring, grants from Tolero Pharmaceuticals, personal fees from Rigel Pharmaceuticals, other from Novartis, personal fees from Genentech, outside the submitted work. Ayman Saad reports personal fees from Magenta Therapeutics, personal fees from Incyte Pharmaceuticals, personal fees from CareDx, outside the submitted work. Partow Kebriaei reports grants from Amgen, grants from Ziopharm, other from Kite, other from Novartis, other from Jazz, other from Pfizer, outside the submitted work. Celalettin Ustun reports not relevant, but honoria from Novartis and Blueprint for attending advisory board meeting. Fiona He reports personal fees from Magenta Therapeutics, outside the submitted work. Sunil Abhyankar reports other from Incyte Corporation, other from Therkos, outside the submitted work. Navneet Majhail reports personal fees from lncyte, personal fees from Anthem, Inc., personal fees from Nkarta, personal fees from Mallinckrodt, outside the submitted work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}